Monte Rosa Therapeutics (GLUE) Shares Issued (2023 - 2025)
Historic Shares Issued for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $348000.0.
- Monte Rosa Therapeutics' Shares Issued changed N/A to $348000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $362000.0, marking a year-over-year decrease of 9950.4%. This contributed to the annual value of $50.0 million for FY2024, which is 10000.0% up from last year.
- Monte Rosa Therapeutics' Shares Issued amounted to $348000.0 in Q3 2025.
- In the past 5 years, Monte Rosa Therapeutics' Shares Issued registered a high of $49.8 million during Q2 2024, and its lowest value of $14000.0 during Q1 2025.
- Its 3-year average for Shares Issued is $9.4 million, with a median of $622500.0 in 2023.
- Per our database at Business Quant, Monte Rosa Therapeutics' Shares Issued surged by 544671.13% in 2024 and then crashed by 9430.89% in 2025.
- Quarter analysis of 3 years shows Monte Rosa Therapeutics' Shares Issued stood at $23.0 million in 2023, then soared by 116.47% to $49.8 million in 2024, then plummeted by 99.3% to $348000.0 in 2025.
- Its Shares Issued stands at $348000.0 for Q3 2025, versus $14000.0 for Q1 2025 and $49.8 million for Q2 2024.